Case Report
Year: 2021 | Month: August | Volume: 11 | Issue: 8 | Pages: 127-130
DOI: https://doi.org/10.52403/ijhsr.20210818
Co-Infection of Mucormycosis and Actinomycosis in COVID-19 Infection
Sunil V Jagtap1, Atul Hulwan2, Snigdha Vartak3, Ramnik Singh4, Swati S. Jagtap5
1Professor, Department of Pathology, Krishna Institute of Medical Sciences Deemed University, Karad, India.
2Assistant Professor, Department of Pathology, Krishna Institute of Medical Sciences Deemed University, Karad, India.
3,4Assistant Lecturer, Department of Pathology, Krishna Institute of Medical Sciences Deemed University, Karad, India.
5Associate Professor, Department of Physiology, Krishna Institute of Medical Sciences Deemed University, Karad, India.
Corresponding Author: Swati Sunil Jagtap
ABSTRACT
Coronavirus disease 2019 (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 infection may be associated with a wide range of bacterial and fungal co-infections.
Herewith a case of 46 year-old male patient of post COVID-19 developed co-infection. He had received steroid treatment and improved in last month. He is known case of diabetes type II since last one year and was on treatment. Now presented to our hospital having fever, facial pain, and swelling mid-face region. His RT-PCR test was positive. The CT scan of the nasal septum, medial walls of bilateral maxillary, ethmoid, sphenoid and frontal sinuses exteding into bilateral nasal cavities. Features suggestive of infective pathology invasive fungal rhinosinusitis On clinical, radio imaging and on histopathological findings diagnosed as maxillary mucormycosis with actinomycosis.
Conclusion: We are presenting this rare case of COVID-19 associated with co-infection of mucormycosis and actinomycosis for its clinical, radio imaging, and on histopathological findings.
Key words: Coronavirus Disease 2019 (COVID-19), Mucormycosis, Actinomycosis, Co-infections.